Cilag

Cilag AG, headquartered in Schaffhausen is an internationally active Swiss pharmaceutical company. It provides as a production company of the pharmaceutical division of Johnson & Johnson, to the Cilag AG since 1959, drugs and pharmaceutical products here. The company employs approximately 1,300 employees (as of early 2009 ) and in 2006 generated according to the trade newspaper 360 million Swiss francs.

Field of activity

Cilag comprises of two areas of pharmaceuticals and chemicals. In the pharmaceutical industry, the company provides a strategic market launch and production location for some of the most important pharmaceutical products by Johnson & Johnson dar. Produced various pharmaceutical dosage forms, these include:

• Parenteral forms: injection vials with freeze-dried contents, injection vials and syringes with liquid contents
• Solid forms: tablets, coated tablets, hormonal tablets, capsules
• Semi-solid forms: suppositories, ovules, ointments

In addition, for the division Cilag " Advanced Sterilization Products " from Johnson & Johnson special cassette for the sterilization of medical or surgical equipment and instruments forth. In Chemicals Cilag introduces development and launch center for chemical substances and export them in more than 40 countries.

History

The company was founded in 1936 sen by the chemist and son of the Schaffhausen district and school doctor Bernhard Joos. founded. This returned in 1933 after a long training stay in the United States to Schaffhausen and started in a small research laboratory with the development of new remedies. The result was first nominated by him medication Pyridacil for disinfection of the kidney and urinary tract. In May 1936 Joos had his company under the name " CILAG, Industrial Chemical Laboratory Ltd." entered in the Commercial Register. First President of the Board was of the Zurich University Professor Carl Naegeli, but in 1942 died.

Within a few years, the research team of the newly founded company developed six new pharmaceutical products to market. Immediately after the war in Europe, the company began in May 1945, which also export up to that preparations sold in Switzerland abroad. After Joos 1949 under pressure from the banks withdrew from the company that Cilag came into the sphere of influence of the Inter- trade. At the same time, international expansion began with the founding of a subsidiary in Vienna. Three years later it opened a branch in Germany and in 1961 another subsidiary in Milan.

1959 Cilag was acquired by Johnson & Johnson. The integration into the U.S. Group allowed the company access to a comprehensive basic research, so that the research and development activities of Cilag experienced a strong expansion and the company became a strategic pharmaceutical development and manufacturing facility for Johnson & Johnson.